Alkem LaboratoriesNSE:ALKEM +1.13%97 Days Inventory is 243.74 as of Mar. 2026, which is 22% above its 10-year median of 199.91. GuruFocus rates NSE:ALKEM with a GF Score™ of 97/100 and a GF Value™ of ₹6,085.79 (Fairly Valued). The stock has 1 warning sign investors should review. Among 919 Drug Manufacturers companies, Alkem Laboratories ranks worse than 69.1% on this metric.
The historical rank and industry rank for Alkem Laboratories's Days Inventory or its related term are showing as below:
NSE:ALKEM'
s Days Inventory Range Over the Past 10 Years
Min: 165.89 Med: 199.91 Max: 226.59
Current: 221.29
During the past 13 years, Alkem Laboratories's highest Days Inventory was 226.59. The lowest was 165.89. And the median was 199.91.
NSE:ALKEM's Days Inventory is ranked worse than 69.1% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:ALKEM: 221.29
Alkem Laboratories's Days Inventory
increased
from Mar. 2025 (208.45) to Mar. 2026 (243.74).
It might indicate that Alkem Laboratories's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Alkem Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.37.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alkem Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.93.
Alkem Laboratories (NSE:ALKEM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Alkem Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alkem Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Alkem Laboratories Days Inventory Related Terms
Alkem Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Alkem Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkem Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Alkem Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkem Laboratories (NSE:ALKEM) has a Days Inventory of 243.74 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alkem Laboratories and its competitors. This is 22% above median its historical median of 199.91. Over the past decade, Alkem Laboratories' Days Inventory has ranged from 165.89 to 226.59. According to the industry distribution chart, Alkem Laboratories ranks #635 out of 919 companies in the Drug Manufacturers industry, placing it in the top 69.1%.
Is Alkem Laboratories' Days Inventory too high?
Alkem Laboratories' current Days Inventory of 243.74 is 22% above median its 10-year median of 199.91. Over the past 10 years, this metric has ranged from a low of 165.89 to a high of 226.59. The Drug Manufacturers industry median Days Inventory is 164.48. Alkem Laboratories' value of 243.74 is 48.2% above this industry median. Based on the distribution chart, Alkem Laboratories ranks #635 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Alkem Laboratories has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alkem Laboratories' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Alkem Laboratories ranks #635 out of 919 companies for Days Inventory. This places Alkem Laboratories in the lower half of its industry. The industry median Days Inventory is 164.48. Alkem Laboratories' value of 243.74 is 48.2% above this benchmark. Historically, Alkem Laboratories' own Days Inventory has ranged from 165.89 to 226.59 over the past decade. While the company's 10-year median is 199.91 vs. the industry median of 164.48, Alkem Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alkem Laboratories's current Days Inventory of 243.74 is 48.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alkem Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alkem Laboratories's current Days Inventory is 243.74, which is 22% above median its own 10-year median of 199.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alkem Laboratories (NSE:ALKEM) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,085.79, compared to a current price of ₹5,562.50 — trading 8.6% below its estimated fair value. The current Days Inventory is 243.74, which is 22% above median its 10-year median of 199.91 and 48.2% above the Drug Manufacturers industry median of 164.48. Alkem Laboratories' overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Alkem Laboratories (NSE:ALKEM), the current Days Inventory is 243.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alkem Laboratories (NSE:ALKEM) Overvalued in 2026?
Based on GuruFocus' analysis, Alkem Laboratories stock appears to be undervalued.
The current stock price of ₹5,562.50 is trading 8.6% below its estimated GF Value™ of ₹6,085.79.
GuruFocus considers Alkem Laboratories to be Fairly Valued.
Key valuation signals for NSE:ALKEM:
Days Inventory: 243.74 (22% above median its 10-year median of 199.91)
GF Value™: ₹6,085.79 vs. price of ₹5,562.50 (8.6% below fair value)
Industry Position: 48.2% above the Drug Manufacturers median (#635 of 919)
No single metric tells the full story. See the NSE:ALKEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
97GF Score
Get the complete analysis for NSE:ALKEM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ALKEM has been successfully added to your 
